Gero

[Not Yet Scheduled]
Gero is an AI-driven drug discovery platform.
Our AI platform is next-generation comparing to what is currently known. Unlike the previous AI generation which is capable of finding correlations, we discover cause-effect relations in big biodata. This ability is based on using complex dynamic system approaches from physics in addition to advanced machine learning to analyze big data.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Singapore
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
PFKFB3 inhibitor
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker